ORTEXORTEX News
Tracking LMB? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LM
Earnings PreviewLMB

LMB Heads Into Earnings with Insiders Selling and Analysts Trimming Targets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 5 Aug 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Limbach Holdings reports Q2 results today with a notable gap between where the stock trades and where those closest to the company have been placing their bets.

The most telling signal ahead of this print is persistent insider selling. The CFO, Jayme Brooks, sold more than $1.4 million worth of shares across five separate transactions between March and late April, with prices ranging from $77 to $100. A divisional president added further sales in June at prices around $79–$81 — close to where the stock now trades at $77.11. Net insider activity over the past 90 days totals roughly $2.6 million in disposals. That pattern doesn't represent a single opportunistic sale; it's a sustained exit at levels above current prices that the earnings print will now need to address.

The analyst community tells a similarly cautious story. The consensus mean target of $115.60 implies meaningful upside from current levels, but the direction of recent moves has been consistently downward. Stifel's analyst has trimmed his Buy-rated target four times since October 2025, cutting from $146 to $104. JP Morgan moved to the sidelines at a $90 target in March. The bull case centers on Limbach's owner-direct service model, M&A capacity, and geographic expansion across the East and Midwest — a mix-shift strategy that has historically supported stronger margins than peers. Bears point to execution risk on that transition, competitive pressure in the bidding environment, and the lumpiness of non-residential construction demand. With the stock already down sharply from its highs and the EPS surprise factor ranked in the 90th percentile of the universe, the market is leaning on Limbach's track record of beating estimates to justify re-engagement.

Positioning in the lending market offers little drama. Borrow availability is well-supplied at roughly 206% — meaning there are around two shares available to lend for every one already borrowed — and the cost to borrow is negligible at 0.51%. Short interest has crept up about 23% over the past month in share terms, but the absolute level remains modest. Options traders are leaning mildly bullish: the put/call ratio of 0.40 runs below its 20-day average of 0.51, and the stock gained 5.3% on Tuesday alone, outpacing peers like PRIM (+4.1%) and TPC (+2.4%) on the week. The two most recent earnings prints, however, both produced single-day declines of nearly 7%, so the recent momentum rally into today's release raises the bar for the result.

The print is therefore less a test of whether Limbach can beat estimates — history suggests it can — and more a test of whether management's commentary on margin trajectory and M&A pipeline is strong enough to reverse a year-long pattern of analyst target cuts and C-suite selling.

Stocks in this article

See the live data behind this article on ORTEX.

Open LMB on ORTEX →

How this article was generated

Generated
5 Aug 2026, 04:39
Data as of
5 Aug 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.